Datta KK - Search Results

1

Phaeohyphomycosis caused by Exophiala spinifera in India.

Rajendran C, Khaitan BK, Mittal R, Ramam M, Bhardwaj M, Datta KK. Rajendran C, et al. Among authors: datta kk. Med Mycol. 2003 Oct;41(5):437-41. doi: 10.1080/1369378031000153820. Med Mycol. 2003. PMID: 14653520

2

Chromoblastomycosis in India.

Rajendran C, Ramesh V, Misra RS, Kandhari S, Upreti HB, Datta KK. Rajendran C, et al. Among authors: datta kk. Int J Dermatol. 1997 Jan;36(1):29-33. doi: 10.1046/j.1365-4362.1997.00008.x. Int J Dermatol. 1997. PMID: 9071611 Review.

3

Cryptococcosis in India: the awakening of a giant?

Banerjee U, Datta K, Majumdar T, Gupta K. Banerjee U, et al. Med Mycol. 2001 Feb;39(1):51-67. doi: 10.1080/mmy.39.1.51.67. Med Mycol. 2001. PMID: 11270408 Review.

4

Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India.

Banerjee U, Datta K, Casadevall A. Banerjee U, et al. Med Mycol. 2004 Apr;42(2):181-6. doi: 10.1080/13693780310001615376. Med Mycol. 2004. PMID: 15124872

5

Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care.

Datta K, Jain N, Sethi S, Rattan A, Casadevall A, Banerjee U. Datta K, et al. J Antimicrob Chemother. 2003 Oct;52(4):683-6. doi: 10.1093/jac/dkg399. Epub 2003 Sep 1. J Antimicrob Chemother. 2003. PMID: 12951350

6

Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.

Goswami R, Dadhwal V, Tejaswi S, Datta K, Paul A, Haricharan RN, Banerjee U, Kochupillai NP. Goswami R, et al. J Infect. 2000 Sep;41(2):162-6. doi: 10.1053/jinf.2000.0723. J Infect. 2000. PMID: 11023762

7

Towards a vaccine for Cryptococcus neoformans: principles and caveats.

Datta K, Pirofski LA. Datta K, et al. FEMS Yeast Res. 2006 Jun;6(4):525-36. doi: 10.1111/j.1567-1364.2006.00073.x. FEMS Yeast Res. 2006. PMID: 16696648 Review.

8

Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Maitta RW, Datta K, Lees A, Belouski SS, Pirofski LA. Maitta RW, et al. Infect Immun. 2004 Jan;72(1):196-208. doi: 10.1128/IAI.72.1.196-208.2004. Infect Immun. 2004. PMID: 14688097 Free PMC article.

9

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K, Pirofski LA. Maitta RW, et al. Infect Immun. 2004 Aug;72(8):4810-8. doi: 10.1128/IAI.72.8.4810-4818.2004. Infect Immun. 2004. PMID: 15271943 Free PMC article.

10

Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.

Maitta RW, Datta K, Pirofski LA. Maitta RW, et al. Vaccine. 2004 Sep 28;22(29-30):4062-8. doi: 10.1016/j.vaccine.2004.03.060. Vaccine. 2004. PMID: 15364457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters